Pharma Stock Roundup LLYs Zepbound Success, FDA Updates for MRK, JNJ
| MMDEX Fund | USD 51.23 0.30 0.58% |
Slightly above 62% of Praxis Growth's investor base is looking to short. The analysis of overall sentiment of trading Praxis Growth Index mutual fund suggests that many investors are alarmed at this time. Praxis Growth's investing sentiment can be driven by a variety of factors including economic data, Praxis Growth's earnings reports, geopolitical events, and overall market trends.
Praxis |
LLYs Zepbound shows better weight loss than NVOs Wegovy in a study. FDA updates for MRK, RHHBY, JNJ and AZN drugs grab headlines.
Read at zacks.com
 |
Praxis Growth Fundamental Analysis
We analyze Praxis Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Praxis Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Praxis Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Praxis Growth is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Praxis Growth Index Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Praxis Growth mutual fund to make a market-neutral strategy. Peer analysis of Praxis Growth could also be used in its relative valuation, which is a method of valuing Praxis Growth by comparing valuation metrics with similar companies.
Peers
Praxis Growth Related Equities
| UIPMX | Precious Metals | 2.56 | ||||
| GLRBX | James Balanced | 0.48 | ||||
| GCEBX | Goldman Sachs | 0.69 | ||||
| FRGOX | Franklin Gold | 2.61 | ||||
| USERX | Gold | 3.05 | ||||
| EPGFX | Europac Gold | 3.56 | ||||
| OGMCX | Oppenheimer Gold | 3.63 |
Other Information on Investing in Praxis Mutual Fund
Praxis Growth financial ratios help investors to determine whether Praxis Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Praxis with respect to the benefits of owning Praxis Growth security.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |